View in EDS

Rituximab decreases the risk of lymphoma in patients with HTV-associated multicentric Castleman disease.

Saved in:
Bibliographic Details
Title: Rituximab decreases the risk of lymphoma in patients with HTV-associated multicentric Castleman disease.
Authors: Gérard, Laurence1 laurence.gerard@sls.aphp.fr, Michot, Jean-Marie1, Burcheri, Sara1, Fieschi, Claire1, Longuet, Pacale2, Delcey, Véronique3, Meignin, Véronique4, Agbalika, Felix5, Chevret, Sylvie6, Oksenhendler, Eric1, Galicier, Lionel1
Source: Blood. 3/8/2012, Vol. 119 Issue 10, p2228-2233. 6p.
Database: Academic Search Ultimate
Be the first to leave a comment!
You must be logged in first